NDC 15631-0105

CANTHARIS

Cantharis

CANTHARIS is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Lytta Vesicatoria.

Product ID15631-0105_7180d045-050e-4f0e-ac51-1aaa5eff57c0
NDC15631-0105
Product TypeHuman Otc Drug
Proprietary NameCANTHARIS
Generic NameCantharis
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-06
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameLYTTA VESICATORIA
Active Ingredient Strength3 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0105-0

100 PELLET in 1 PACKAGE (15631-0105-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0105-4 [15631010504]

CANTHARIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0105-5 [15631010505]

CANTHARIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0105-2 [15631010502]

CANTHARIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0105-0 [15631010500]

CANTHARIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0105-3 [15631010503]

CANTHARIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

NDC 15631-0105-1 [15631010501]

CANTHARIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-02-19

Drug Details

Active Ingredients

IngredientStrength
LYTTA VESICATORIA3 [hp_X]/1

OpenFDA Data

SPL SET ID:642a1b2d-05cf-4711-b121-487e62eabf62
Manufacturer
UNII

NDC Crossover Matching brand name "CANTHARIS" or generic name "Cantharis"

NDCBrand NameGeneric Name
0220-1079CantharisLYTTA VESICATORIA
0220-1082CantharisLYTTA VESICATORIA
0220-1083CantharisLYTTA VESICATORIA
0220-1088CantharisLYTTA VESICATORIA
0220-1091CantharisLYTTA VESICATORIA
0220-1092CantharisLYTTA VESICATORIA
0220-1111CantharisLYTTA VESICATORIA
0220-1114CantharisLYTTA VESICATORIA
0220-1115CantharisLYTTA VESICATORIA
0220-1145CantharisLYTTA VESICATORIA
0360-0093CANTHARISCANTHARIS
0360-0094CANTHARISCANTHARIS
15631-0105CANTHARISCANTHARIS
15631-0552CANTHARISCANTHARIS
15631-2311CANTHARISCANTHARIS
53645-1660CantharisCantharis
54973-0609CANTHARISlytta vesicatoria
54973-2909CANTHARISlytta vesicatoria
60512-9151CANTHARISCANTHARIS
62106-6607CANTHARISCantharides
63083-7111CantharisCantharis
68428-284CantharisLYTTA VESICATORIA
71919-158CantharisLYTTA VESICATORIA
76472-3010CantharisLYTTA VESICATORIA
69152-1015Cantharis 200CCantharis
69152-1213Cantharis 6CCantharis

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.